Search Results - "Scudday, Travis S."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Wear of Third-Generation Cross-Linked Polyethylene in Primary Total Hip Arthroplasty: A 10-Year Analysis by Jalali, Omid, Fiske, Joseph, DeJardin, Michael G., Scudday, Travis S., Barnett, Steven L., Gorab, Robert S.

    Published in The Journal of arthroplasty (01-05-2024)
    “…Sequential modifications to the manufacturing process of highly cross-linked polyethylene (HXLPE) have improved the wear resistance and implant survival of…”
    Get full text
    Journal Article
  2. 2

    Retained Functional Antibiotic Hip Spacers Have High Rates of Stem Loosening, Subsidence, and Reoperation by Vargas-Vila, Mario A., Siljander, Matthew P., Scudday, Travis S., Patel, Jay J., Barnett, Steven L., Nassif, Nader A.

    Published in The Journal of arthroplasty (01-07-2023)
    “…Functional antibiotic hip spacers for treatment of periprosthetic joint infection may be retained in patients deemed too sick for reimplantation, or who elect…”
    Get full text
    Journal Article
  3. 3

    Use of Tetrahydrocannabinol and Cannabidiol Products in the Perioperative Period Around Primary Unilateral Total Hip and Knee Arthroplasty by Runner, Robert P., Luu, Andrew N., Nassif, Nader A., Scudday, Travis S., Patel, Jay J., Barnett, Steven L., Gorab, Robert S.

    Published in The Journal of arthroplasty (01-06-2020)
    “…Given the opioid crisis in America, patients are trying alternative medications including tetrahydrocannabinol (THC) and other cannabidiol (CBD) containing…”
    Get full text
    Journal Article
  4. 4

    Conversion Total Hip Arthroplasty in the Era of Bundled Care Payments: Impacts on Costs of Care by Hunter, Michael D., Desmarais, Jason D., Quilligan, Edward J., Scudday, Travis S., Patel, Jay J., Barnett, Steven L., Gorab, Robert S., Nassif, Nader A.

    Published in The Journal of arthroplasty (01-06-2023)
    “…Conversion hip arthroplasty is defined as a patient who has had prior open or arthroscopic hip surgery with or without retained hardware that is removed and…”
    Get full text
    Journal Article
  5. 5

    Opioid Use After Discharge Following Primary Unilateral Total Hip Arthroplasty: How Much Are We Overprescribing? by Runner, Robert P., Luu, Andrew N., Thielen, Zachary P., Scudday, Travis S., Nassif, Nader A., Patel, Jay J., Barnett, Steven L., Gorab, Robert S.

    Published in The Journal of arthroplasty (01-06-2020)
    “…The opioid crisis pressures orthopedic surgeons to reduce the amount of narcotics prescribed for postoperative pain management. This study sought to quantify…”
    Get full text
    Journal Article
  6. 6

    Opioid Use After Discharge Following Primary Unilateral Total Knee Arthroplasty: How Much Are We Over-Prescribing? by Runner, Robert P., Luu, Andrew N., Thielen, Zachary P., Scudday, Travis S., Nassif, Nader A., Patel, Jay J., Barnett, Steven L., Gorab, Robert S.

    Published in The Journal of arthroplasty (01-06-2020)
    “…The opioid crisis pressures orthopedic surgeons to reduce the amount of narcotics prescribed for post-operative pain management. This study sought to quantify…”
    Get full text
    Journal Article
  7. 7

    Systemic Versus Topical Tranexamic Acid: How Best to Dose and Administer by Amin, Nirav H, Scudday, Travis S, Cushner, Fred D

    “…Tranexamic acid, a potent antifibrinolytic is widely accepted as an effective medication for blood conservation during hip and knee arthroplasty. There remain…”
    Get full text
    Journal Article